Japanese Paper and Forestry Products Stock News

TSE:6544
TSE:6544Commercial Services

Japan Elevator Service Holdings (TSE:6544) Valuation Check After Strong Nine Month Earnings Update

Japan Elevator Service Holdings Ltd (TSE:6544) drew investor attention after reporting nine-month earnings to December 31, 2025, with sales of ¥41,546 million and net income of ¥5,032 million, both above the prior year. See our latest analysis for Japan Elevator Service HoldingsLtd. The latest nine month earnings update comes after a softer period for the share price, with a 1 day share price return of 1.71% but a 90 day share price return decline of 11.45% and a 1 year total shareholder...
TSE:6965
TSE:6965Electronic

Hamamatsu Photonics K.K. (TSE:6965) Valuation Check After Mixed Earnings And New Full Year Outlook

Hamamatsu Photonics K.K. (TSE:6965) has drawn fresh attention after reporting first quarter earnings, showing higher sales but lower net income year over year, along with new full year 2026 guidance. See our latest analysis for Hamamatsu Photonics K.K. The recent first quarter earnings and new full year guidance arrive after a mixed stretch for investors. A 12.42% 90 day share price return contrasts with a 45.53% decline in the 3 year total shareholder return, suggesting shorter term momentum...
TSE:4592
TSE:4592Biotechs

Asian Growth Stocks With Insider Ownership Boasting 120% Earnings Growth

As global markets navigate the complexities of AI disruption and economic uncertainties, Asian equities present a compelling landscape for growth-oriented investors. In this environment, companies with substantial insider ownership and robust earnings growth stand out as potentially strong candidates for those looking to align with management interests and capitalize on promising financial trajectories.
TSE:7832
TSE:7832Leisure

Should BANDAI NAMCO’s Upgraded Guidance and ¥30 Billion Buyback Prompt Action From (TSE:7832) Investors?

In February 2026, BANDAI NAMCO Holdings Inc. approved a share repurchase program of up to 6,000,000 shares for ¥30,000 million, raised its full-year earnings guidance, and outlined higher regular and performance-based dividends for the year ending March 31, 2026. Together, the upgraded profit outlook, buyback authorization, and richer dividend policy highlight management’s emphasis on capital efficiency and shareholder returns within its new Mid-term Plan. We’ll now examine how the...
TSE:9716
TSE:9716Professional Services

Should Nomura’s 2026 Management Overhaul and Reorganization Reshape Its Governance Story for (TSE:9716) Investors?

Nomura Co., Ltd. has announced extensive executive officer and executive fellow personnel changes, alongside a major organizational restructuring, set to take effect on March 1, 2026, including new roles overseeing domestic business, corporate functions, overseas operations, sustainability, and creative divisions. The combination of refreshed leadership responsibilities and the breakup of large headquarters into more focused units signals an effort to tighten corporate governance and...
TSE:9501
TSE:9501Electric Utilities

Tokyo Electric Power (TSE:9501) Projects Large Net Loss Despite Operating Profit Guidance – What Is Driving It?

Tokyo Electric Power Company Holdings, Incorporated recently issued consolidated earnings guidance for the year ending March 31, 2026, projecting net sales of ¥6,462.00 billion, operating income of ¥277.00 billion, and a net loss attributable to owners of the parent of ¥641.00 billion, equivalent to a net loss per share of ¥400.11. This contrast between expected positive operating income and a very large projected bottom-line loss highlights the scale of non-operating or exceptional...
TSE:4528
TSE:4528Pharmaceuticals

Will Stronger EPS From Nine-Month Results Change Ono Pharmaceutical's (TSE:4528) Narrative?

Ono Pharmaceutical Co., Ltd. reported past earnings for the nine months ended December 31, 2025, with sales of ¥397,036 million and net income of ¥68,949 million, both higher than the same period a year earlier. The increase in both basic and diluted earnings per share from continuing operations highlights improved profitability, which can be an important consideration for investors assessing the company’s performance. Next, we will examine how Ono Pharmaceutical’s improved earnings per...
TSE:4452
TSE:4452Personal Products

Does Kao’s 2026 Guidance, Share Split and Dividend Shift Change The Bull Case For Kao (TSE:4452)?

Kao Corporation recently reported full-year 2025 results showing higher sales of ¥1,688,633 million and net income of ¥120,081 million, alongside new 2026 guidance, a planned share split with increased authorized shares, and updated dividend payments. The combination of earnings growth, a move to double authorized share capital for the upcoming split, and shifts in dividend policy gives investors fresh information on Kao’s capital allocation and future per-share metrics. We’ll now explore...